5 Best Biotech Stocks to Invest In
A clinical-stage biopharmaceutical company Global Blood Therapeutics, Inc. (NASDAQ: GBT) is the long-running investment of a billionaire hedge fund manager. The firm first initiated a stake in Global...
Travere Therapeutics Inc. (TVTX)
Get Email AlertsSector: Pharmaceutical Preparations
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | 45,000,000 | $390,119 | 5.69% | ||
| 2. | RA Capital Management Peter Kolchinsky | 4,635,687 | $85,575 | 1.56% | |
| 3. | Perceptive Advisors Joseph Edelman | 3,240,112 | $59,812 | 0.87% | |
| 4. | 53,400,000 | $44,684 | +46% | 2.4% | |
| 5. | Renaissance Technologies Jim Simons | 1,957,154 | $36,129 | -2% | 0.03% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $17.85 | 5,000 | Officer, Director | 245,556 | 2017-06-14 | Filing | |
| $15.31 | 5,000 | Director | 52,000 | 2016-03-04 | Filing | |
| $8.60 | 15,000 | Director | 35,000 | 2014-11-25 | Filing | |
| $8.38 | 6,100 | Director | 129,165 | 2014-11-21 | Filing | |
| $8.50 | 8,700 | Officer, Director | 371,756 | 2014-11-21 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $27.01 | 688 | Officer | 24,055 | 2021-01-06 | Filing | |
| $26.65 | 688 | Officer | 24,743 | 2021-01-05 | Filing | |
| $27.01 | 3,438 | Officer, Director | 87,819 | 2021-01-06 | Filing | |
| $26.65 | 3,438 | Officer, Director | 91,257 | 2021-01-05 | Filing | |
| $26.02 | 5,549 | Director | 196,667 | 2020-12-15 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 1,750,000 | $1,732 | 1.75% | |
| 2. | 0 | $0 | 0% | |
| 3. | 0 | $0 | 0% | |
| 4. | 0 | $0 | 0% | |
| 5. | 0 | $0 | 0% |
News See All
Billionaire Hedge Funds
